Home › Prescription medicine › Dr. Reddy's Laboratories, Inc. — Tacrolimus…
Dr. Reddy's Laboratories, Inc. — Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
The Recall Registry rates this serious — FDA Class II: temporary or medically reversible health harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Dr. Reddy's Laboratories, Inc.
The product
Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01
Details
- Units affected
- 8,280 bottles
- Recall date
- December 15, 2023
- Brand
- Dr. Reddy's Laboratories, Inc.
US Nationwide
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Dr. Reddy's Laboratories, Inc. — Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine